Estrella Immunopharma, Inc. (ESLA) vs Palatin Technologies, Inc. (PTN)
A side-by-side comparison of Estrella Immunopharma, Inc. and Palatin Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ESLA
Estrella Immunopharma, Inc.
$0.44HealthcareDelayed quote: Oct 6, 2026, 12:21 PM EDT
PTN
Palatin Technologies, Inc.
$9.42HealthcareDelayed quote: Oct 6, 2026, 12:17 PM EDT
Total return — ESLA vs PTN
growth of $100 · dividends reinvested · last 5yESLA -95.5% (-46.2%/yr)PTN -98.5% (-56.6%/yr)ESLA compounded faster over this window
ESLA PTN
ESLA vs PTN: by the numbers
- •ESLA is the larger company ($19M vs $17M market cap).
- •Both run net losses; ESLA's is the smaller (0.00% vs -63.54% net margin).
Metrics side by side
Valuation
| Metric | ESLA | PTN |
|---|---|---|
| P/S ratio | N/A | 1.27 |
| P/B ratio | N/A | 2.51 |
Profitability
| Metric | ESLA | PTN |
|---|---|---|
| Gross margin | 0.00% | 99.63% |
| Operating margin | 0.00% | -65.74% |
| Net margin | 0.00% | -63.54% |
| ROE | N/A | -125.30% |
| ROIC | N/A | -125.44% |
Growth (annualized)
| Metric | ESLA | PTN |
|---|---|---|
| Total return CAGR (5Y) | -46.34% | -55.41% |
Frequently asked
- How have ESLA and PTN total returns compared?
- Over the past 5 years, ESLA delivered -46.34% and PTN delivered -55.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.